Drug Discovery World

JUNE 29, 2023

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Drug Discovery World

JUNE 22, 2023

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Drug Discovery World

FEBRUARY 8, 2024

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences.

Gene Therapy 59

Gene Therapy Gene Bioinformatics Life Science 59

Drug Discovery World

OCTOBER 3, 2023

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences.

Gene Therapy 52

Gene Therapy Gene Life Science Bioinformatics 52

Scienmag

MAY 24, 2021

BiATA 2021 Modern life science studies involve both biological and computational methods. The ultimate goal of the conference is to bring together bioinformaticians and biologists to share experience in development and practical application of bioinformatics algorithms. […].

Bioinformatics 40

Bioinformatics Life Science Development 40

BioTech 365

OCTOBER 8, 2020

NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of … Continue reading →

Bioinformatics 40

Bioinformatics Life Science Research 40

BioTech 365

SEPTEMBER 3, 2020

Cellevolve Bio Founder & CEO will provide strategic, scientific and commercial expertise CHICAGO–(BUSINESS WIRE)–Portal Innovations, LLC, a national life sciences, medtech and bioinformatics start-up incubator today announced that Derrell D. Porter, M.D. is joining the Company as a Board Member.

Bioinformatics 52

Bioinformatics Life Science 52

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine.

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

JANUARY 19, 2022

This will provide researchers with the option to analyse their data without the need to learn code, which can be a challenging requirement for those not au fait with bioinformatics. Research Instruments is the main distributor for genomic and life science research products in the region.

RNA 72

RNA Research Life Science Bioinformatics 72

XTalks

MAY 20, 2022

Depending on the type of field or company, you can pursue clinical scientist jobs with a major in biology, medicine, medical technology, chemistry, immunology and other related life science and pre-medical degrees. Below is a brief preview from the National Health Services’ list of healthcare science fields: Vascular Science.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

Drug Discovery World

JULY 11, 2023

Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?

Big Data 40

Big Data Development Life Science Drugs 40

Drug Discovery World

OCTOBER 20, 2023

The acquisition of Olink underscores the profound impact that proteomics is having as our customers continue to advance life science research and precision medicine,” said Marc Casper, Chairman, President and Chief Executive Officer of Thermo Fisher.

Drugs 52

Drugs Antibody DNA Gene Therapy 52

Scienmag

OCTOBER 19, 2020

A new study led by Professor of Life Sciences Shai Pilosof (Ben-Gurion University of the Negev, […]. In a continual evolutionary battle between virus and host, CRISPR-Cas act as a major driving force of strain diversity in host-virus systems.

Life Science 40

Life Science Bioinformatics 40

XTalks

SEPTEMBER 28, 2020

The leading global life science company is set to introduce Resolution Bio’s ctDx Lung assay , a non-invasive liquid biopsy test for patients with non-small cell lung cancer (NSCLC). LabCorp (NYSE:LH) may help lead the way with its backing of Resolution Bioscience’s new diagnostic blood test for lung cancer.

Gene 105

Gene DNA Life Science Genotype 105

Drug Discovery World

OCTOBER 26, 2023

This requirement is met by technology from Evotec, a life sciences company that continually leads the way in proteomic research; with its PanOmics approach, Evotec seamlessly combines both data generation and analysis. Specific analyses and modules can also be easily extended according to additional scientific needs.

Drugs 52

Drugs Protein Genome Genomics 52

Drug Discovery World

DECEMBER 26, 2023

The Chan Lab at UT Southwestern will enhance PhenoScope’s tumour bank with spatial transcriptomic data and provide bioinformatic analytic expertise. SimBioSys and UT Southwestern TechBio company SimBioSys has announced a collaboration with UT Southwestern to develop cancer biomarkers for immunotherapy.

Drugs 52

Drugs Development Medicine Bioinformatics 52

The Pharma Data

MARCH 2, 2021

billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life. We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. Our significant investment of almost 3.5

In-Vivo 52

In-Vivo Contract Manufacturing Bioinformatics Clinical Development 52

pharmaphorum

MAY 27, 2022

data processing systems that support bioinformatics modelling) and digital record systems (e.g. Underrepresentation is multifactorial, so concerted efforts from life science companies are required to address inequitable healthcare. video consultations), health data analytics (e.g.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

JUNE 10, 2022

Before joining BrightInsight, David was a Partner at Boston Consulting Group focused on life sciences, pharmaceuticals, and medical devices.

Marketing 133

Marketing Engineer Bioinformatics Regulation 133

Drug Discovery World

OCTOBER 25, 2023

RA: How accessible have NGS technologies become for life sciences researchers? DG : With the expansion of commercial providers, literally all life science researchers now have easy access to NGS. RA: How important are bioinformatics and data analysis in helping teams analyse sequencing data?

Bioinformatics 115

Bioinformatics Genetics RNA Drugs 115

Drug Discovery World

APRIL 29, 2024

Scott Kobayashi, Senior Vice President of Sales, BioPhy: Kobayashi previously founded Delta Project Management, a life sciences consulting firm he sold to Versita in 2022, and held consulting roles with companies like Pfizer, Genentech, and Flour. He has a PhD in Bioinformatics from the University of Cambridge.

Drugs 52

Drugs Sales Gene Therapy Life Science 52

XTalks

NOVEMBER 7, 2022

Optimal methods for bioinformatic analysis are still needed. There is a high risk of false positives and false negatives (variant allele frequencies [VAFs] at frequencies <0.5 percent show less reliability).

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

XTalks

APRIL 21, 2023

Biotech company Ultima Genomics has joined forces with Genome Insight, a bioinformatics-based biomedicine company, to overcome the caveat of cost and quality in WGS. Ultima Genomics will provide their high-throughput NGS instrument platform, the UG 100, and Genome Insight will provide the bioinformatics platform for data analysis.

Genome 97

Genome Genomics Bioinformatics Genetics 97

pharmaphorum

APRIL 8, 2021

The new funding will also be used to advance two more T cell programmes for head and neck and kidney cancers into human testing, develop and expand its bioinformatics and manufacturing capabilities, and increase its use of automation, according to an SEC filing. The sector raised more than £830 million ($1.14

Research 63

Research Bioinformatics Life Science Manufacturing 63

Drug Discovery World

JULY 19, 2023

Bioinformatics and genetic sequencing are starting to be placed front and centre of public research programmes as scientists from around the world recognise the substantial benefits of knowledge sharing and resource pooling when it comes to genetic science. What does open science look like?

Genome 52

Genome Genomics Bioinformatics Genetics 52

Drug Discovery World

SEPTEMBER 7, 2022

Why is this such a challenge in life sciences? Life science R&D data needs to be centralised… Specialised point solutions for each of your research and development teams can cause significant problems for teams doing data analysis. R&D data is highly complex . Large molecule data is extremely complex.

Scientist 52

Scientist Life Science Antibody Protein 52

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

The Pharma Data

NOVEMBER 15, 2020

Lead Pharma is headquartered at Pivot Park, the biopharmaceutical life sciences campus in Oss, the Netherlands. Contact: Media Inquiries: LifeSpring Life Sciences Communication, Amsterdam Leon Melens Tel.: +31 For more information visit: www.leadpharma.com. Company Inquiries: Lead Pharma Holding B.V.

Licensing 52

Licensing Licensing Development Research 52

XTalks

DECEMBER 13, 2023

This impressive growth can be attributed to Fulgent’s distinctive chemistries and advanced proprietary bioinformatics pipeline, which have been instrumental in fueling the company’s rapid advancement in recent years.

Genetics 111

Genetics Vaccination Vaccine DNA 111

Scienmag

DECEMBER 22, 2020

Under atomic force microscopy (AFM), e.g., their surface can be rapidly scanned, and functional motions monitored, which is of great importance for applications in all fields of Life science. The analysis and interpretation of experimental results remains however challenging because the resolution of […].

Life Science 52

Life Science Protein Bioinformatics Engineer 52

Drug Discovery World

NOVEMBER 13, 2023

Novel/alternative ML-enabled screening technologies for higher POS Following chairperson’s remarks from M Frank Erasmus, PhD, Head, Bioinformatics, Specifica, there will be four presentations and a panel discussion. It is called, ‘An unexpected future for immune oncology therapies?’

Protein 59

Protein Antibody Engineer Scientist 59

Roots Analysis

AUGUST 28, 2022

Recent advances in multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, cytometry and imaging, in combination with bioinformatics and biostatistics, have been translated into several popular bioanalytical platforms, such as next-generation sequencing (NGS), single-cell analysis, flow cytometry and mass spectrometry.

Genome 52

Genome Genomics RNA Genome Project 52

Drug Discovery World

APRIL 21, 2023

SLAS Europe 2023 will take place 22-26 May in Brussels, Belgium, where attendees will embrace the theme Science Set in Motion. DDW’s Multimedia Editor Megan Thomas explores what to expect from the event. The Brussels Expo welcomes more than 100 exhibitors, including many companies whose work makes these tracks possible.

Doctors 52

Doctors Doctor Genetics In-Vitro 52

XTalks

SEPTEMBER 5, 2023

This system integrates mathematical modeling, biological science and bioinformatics and it could identify, report and mitigate new drugs and vaccines faster. Now, the focus has changed, and there is a new challenge for pharma and computer industry partnerships to develop AI-enabled clinical trial technologies or platforms.

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

pharmaphorum

MARCH 28, 2022

AION Labs’ third call for applications seeks computational biologists, bioinformatics and cheminformatics scientists, AI researchers, and antibody or protein engineers at academic and industry research labs worldwide to assemble a fully funded start-up company. About the author .

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

Drug Discovery World

NOVEMBER 9, 2023

Business Partnership Manager, Azenta Life Sciences, on: ‘Innovative antibody discovery workflow leveraging artificial intelligence to prioritise leads’. The session will finish with a panel discussion on protein production lab challenges, focusing on methodologies, strategies and the art of expressing recombinant proteins.

Engineer 52

Engineer Antibody Protein In-Vivo 52

Drug Discovery World

NOVEMBER 30, 2023

It was presented by Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, and titled: ‘AI-based target and antibody discovery from patient tumour profiles’.

Antibody 59

Antibody Protein Engineer In-Vivo 59